These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10484241)

  • 1. Patients with type 2 diabetes: the case for primary prevention.
    Haffner SM
    Am J Med; 1999 Aug; 107(2A):43S-45S. PubMed ID: 10484241
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the metabolic effects of fat-modified vs low fat diets.
    Riccardi G; Parillo M
    Ann N Y Acad Sci; 1993 Jun; 683():192-8. PubMed ID: 8394664
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.
    Steiner G
    Diabetes Care; 1999 Apr; 22 Suppl 3():C6-9. PubMed ID: 10189556
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary prevention of coronary heart disease: integrating risk assessment with intervention.
    Grundy SM
    Circulation; 1999 Aug; 100(9):988-98. PubMed ID: 10468531
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary prevention of type 2 diabetes: how do we do it?
    Abdul-Ghani MA; Sabah M; Minuchin O; Vardi P; Raz I; Wainstein J
    Isr Med Assoc J; 2004 May; 6(5):305-7. PubMed ID: 15151376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood glucose control with high dosage metformin. So that sweet hearts beat longer].
    MMW Fortschr Med; 2002 Jun; 144(24):46-7. PubMed ID: 12138888
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease].
    Cullen P; Assmann G
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):881-7. PubMed ID: 10943220
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical management of type 2 diabetes in indigenous youth.
    Sellers EA; Moore K; Dean HJ
    Pediatr Clin North Am; 2009 Dec; 56(6):1441-59. PubMed ID: 19962030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?
    Feher MD; Elkeles RS
    Heart; 1999 Jan; 81(1):10-1. PubMed ID: 10220537
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on the MRC/BHF Heart Protection Study.
    Sirtori CR
    Lancet; 2003 Aug; 362(9385):744; author reply 744-5. PubMed ID: 12957102
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular prevention in patients with diabetes and prediabetes.
    Anselmino M; Gohlke H; Mellbin L; Rydén L
    Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACCORD, ADVANCE, VADT].
    Shikuma J; Odawara M
    Nihon Rinsho; 2012 May; 70 Suppl 3():273-80. PubMed ID: 22768533
    [No Abstract]   [Full Text] [Related]  

  • 14. CHD and diabetes--target dyslipidaemia, reduce the risk.
    Betteridge DJ; Tuomilehto J
    Diabetes Res Clin Pract; 2003 Jul; 61 Suppl 1():S1-2. PubMed ID: 12880688
    [No Abstract]   [Full Text] [Related]  

  • 15. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
    Vuksan V; Jenkins DJ; Spadafora P; Sievenpiper JL; Owen R; Vidgen E; Brighenti F; Josse R; Leiter LA; Bruce-Thompson C
    Diabetes Care; 1999 Jun; 22(6):913-9. PubMed ID: 10372241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Jaffiol C; Godeau P
    Bull Acad Natl Med; 2015 Oct; 199(7):1211-1213. PubMed ID: 29879340
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.
    Holman RR; Bethel MA; Chan JC; Chiasson JL; Doran Z; Ge J; Gerstein H; Huo Y; McMurray JJ; Ryden L; Liyanage W; Schröder S; Tendera M; Theodorakis MJ; Tuomilehto J; Yang W; Hu D; Pan C;
    Am Heart J; 2014 Jul; 168(1):23-9.e2. PubMed ID: 24952856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on the MRC/BHF Heart Protection Study.
    Abramson J
    Lancet; 2003 Aug; 362(9385):745-6. PubMed ID: 12957104
    [No Abstract]   [Full Text] [Related]  

  • 19. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.